Young Pharmaceuticals Collaborates on Skincare: A New Era in Microbial-Based Solutions

Young Pharmaceuticals has made a bold move in the skincare industry. The company has announced a partnership with LAC2βiome, a leader in microbial-based skincare. Young Pharmaceuticals Partners with Microbial Firm, collaborates on Skincare to create physician-dispensed, scientifically-driven skincare solutions backed by clinical research.

Young Pharmaceuticals Collaborates on Skincare with LAC2βiome for Microbial-Based Products

The collaboration between Young Pharmaceuticals and LAC2βiome marks a significant expansion of their product offerings. LAC2βiome brings expertise in microbial-based ingredients, known for their ability to support skin health. This partnership aligns perfectly with Young Pharmaceuticals’ focus on providing effective, science-backed skincare solutions.

LAC2βiome specializes in both topical skincare and dietary supplements. Their products undergo rigorous scientific research and clinical validation. This ensures that their ingredients are not only effective but also safe for use in skincare routines.

Introducing InfiniteSkin Microbiome: A New Skincare Line Under the BiomeAge Brand

Young Pharmaceuticals will market this new range under the BiomeAge brand. The first product in this line combines hyaluronic acid with lactobacilli, a strain of bacteria known for its ability to maintain a healthy skin microbiome. This powerful combination hydrates and soothes the skin, making it ideal for anti-aging formulations.

“Young Pharmaceuticals Collaborates on Skincare to offer innovative solutions like this one. The new technology delivers live beneficial bacteria to the skin,” explains John Kulesza, president of Young Pharmaceuticals. This aligns with Young’s commitment to medically formulated products that improve skin health.

Personalized Skincare Solutions Exclusively Through Medical Professionals

The new BiomeAge products will be available exclusively through medical offices. Dermatologists and healthcare professionals will offer personalized care to ensure optimal results. Luc Monbourquette, Director of Global Business Development and co-founder, stresses the importance of education in probiotic skincare. “Education is key in building this space, and we see no better partner than Young Pharmaceuticals,” he says.

As biotechnology continues to play a more significant role in personal care, Young Pharmaceuticals’ move into microbial skincare aligns with industry trends. With a network of over 2,000 dermatologists and plastic surgeons, Young Pharmaceuticals is well-positioned to lead the charge in educating consumers and professionals alike.

Explore more news about the latest skincare innovations and industry trends right here on our website!